Skip Navigation
Skip to contents




27 results

Reply: The Characteristics about Our Study in Irritable Bowel Syndrome

Zhuang KM, Guo YB, Liu SD

  • Gut Liver.
  • 2017 Jan;11(1):168-168.
  • doi: 10.5009/gnl16346
No abstract available.
Critical Appraisal of “Association between Diet and Lifestyle Habits and Irritable Bowel Syndrome: A Case-Control Study”

Noseworthy S

  • Gut Liver.
  • 2017 Jan;11(1):166-167.
  • doi: 10.5009/gnl16196
No abstract available.
Colored Ring-Shaped Thread Tag Clippings to Identify the Accurate Location of Multiple Polyps Resected via Endoscopic Mucosal Resection

Mori H, Kobara H, Masaki T

  • Gut Liver.
  • 2017 Jan;11(1):164-165.
  • doi: 10.5009/gnl16197
No abstract available.
Protection Provided by a Gabexate Mesylate Thermo-Sensitive In Situ Gel for Rats with Grade III Pancreatic Trauma

Gao H, Song Q, Lv F, Wang S, Wang Y, Li X, Luo Y, Mei X, Tang J

  • Gut Liver.
  • 2017 Jan;11(1):156-163.
  • doi: 10.5009/gnl15281
BACKGROUND/AIMS: This study investigated the protection provided by gabexate mesylate thermo-sensitive in-situ gel (GMTI) against grade III pancreatic trauma in rats. METHODS: A grade III pancreatic trauma model with main pancreatic...
Feasibility of Endoscopic Papillary Large Balloon Dilation in Patients with Difficult Bile Duct Stones without Dilatation of the Lower Part of the Extrahepatic Bile Duct

Fujita Y, Iwasaki A, Sato T, Fujisawa T, Sekino Y, Hosono K, Matsuhashi N, Sakamaki K, Nakajima A, Kubota K

  • Gut Liver.
  • 2017 Jan;11(1):149-155.
  • doi: 10.5009/gnl15634
BACKGROUND/AIMS: There is no consensus for using endoscopic papillary large balloon dilation (EPLBD) in patients without dilatation of the lower part of the bile duct (DLBD). We evaluated the feasibility...
Antireflux Metal Stent as a First-Line Metal Stent for Distal Malignant Biliary Obstruction: A Pilot Study

Hamada T, Isayama H, Nakai Y, Togawa O, Takahara N, Uchino R, Mizuno S, Mohri D, Yagioka H, Kogure H, Matsubara , Yamamoto N, Ito Y, Tada M, Koike K

  • Gut Liver.
  • 2017 Jan;11(1):142-148.
  • doi: 10.5009/gnl15579
BACKGROUND/AIMS: In distal malignant biliary obstruction, an antireflux metal stent (ARMS) with a funnel-shaped valve is effective as a reintervention for metal stent occlusion caused by reflux. This study sought...
Persistent α-Fetoprotein Elevation in Healthy Adults and Mutational Analysis of α-Fetoprotein Promoter, Enhancer, and Silencer Regions

Jeon Y, Choi YS, Jang ES, Kim JW, Jeong SH

  • Gut Liver.
  • 2017 Jan;11(1):136-141.
  • doi: 10.5009/gnl16069
BACKGROUND/AIMS: α-Fetoprotein (AFP) is normally 1 year, and 20 controls with low AFP levels (
Management of Clevudine-Resistant Chronic Hepatitis B: A Multicenter Cohort Study

Cho EY, Yim HJ, Jung YK, Suh SJ, Seo YS, Kim JH, Kim HS, Lee SH, Ahn SH, Lee JI, Jeong SH, Kim JW, Lee JW, Kim IH, Kim HS, Park SJ, Lee JM, Hwang SG

  • Gut Liver.
  • 2017 Jan;11(1):129-135.
  • doi: 10.5009/gnl15597
BACKGROUND/AIMS: Data are lacking regarding the management of chronic hepatitis B (CHB) with resistance to clevudine (CLV). This study evaluated the efficacy of different rescue therapies for CLV-resistant CHB. METHODS: Patients...
Generation of Multilayered 3D Structures of HepG2 Cells Using a Bio-printing Technique

Jeon H, Kang K, Park SA, Kim WD, Paik SS, Lee SH, Jeong J, Choi D

  • Gut Liver.
  • 2017 Jan;11(1):121-128.
  • doi: 10.5009/gnl16010
BACKGROUND/AIMS: Chronic liver disease is a major widespread cause of death, and whole liver transplantation is the only definitive treatment for patients with end-stage liver diseases. However, many problems, including...
Integrative Analysis of Microarray Data to Reveal Regulation Patterns in the Pathogenesis of Hepatocellular Carcinoma

Chen J, Qian Z, Li F, Li J, Lu Y

  • Gut Liver.
  • 2017 Jan;11(1):112-120.
  • doi: 10.5009/gnl16063
BACKGROUND/AIMS: The integration of multiple profiling data and the construction of a transcriptional regulatory network may provide additional insights into the molecular mechanisms of hepatocellular carcinoma (HCC). The present study...
Elk-3 Contributes to the Progression of Liver Fibrosis by Regulating the Epithelial-Mesenchymal Transition

Li TZ, Kim SM, Hur W, Choi JE, Kim JH, Hong SW, Lee EB, Lee JH, Yoon SK

  • Gut Liver.
  • 2017 Jan;11(1):102-111.
  • doi: 10.5009/gnl15566
BACKGROUND/AIMS: The role of Elk-3 in the epithelial-mesenchymal transition (EMT) during liver fibrogenesis remains unclear. Here, we determined the expression of Elk-3 in in vitro and in vivo models and...
Diagnostic Accuracy of Hepatic Vein Arrival Time Performed with Contrast-Enhanced Ultrasonography for Cirrhosis: A Systematic Review and Meta-Analysis

Kim G, Shim KY, Baik SK

  • Gut Liver.
  • 2017 Jan;11(1):93-101.
  • doi: 10.5009/gnl16031
BACKGROUND/AIMS: We identified reports in the literature regarding the diagnostic accuracy of hepatic vein arrival time (HVAT) measured by contrast-enhanced ultrasonography (CEUS) to assess hepatic fibrosis in cirrhosis. METHODS: The Ovid...
Quality of Life after Endoscopic Submucosal Dissection for Early Gastric Cancer: A Prospective Multicenter Cohort Study

Kim SG, Ji SM, Lee NR, Park SH, You JH, Choi IJ, Lee WS, Park SJ, Lee JH, Seol SY, Kim JH, Lim CH, Cho JY, Kim GH, Chun HJ, Lee YC, Jung HY, Kim JJ

  • Gut Liver.
  • 2017 Jan;11(1):87-92.
  • doi: 10.5009/gnl15549
BACKGROUND/AIMS: Endoscopic submucosal dissection (ESD) has been an established treatment for indicated early gastric cancer (EGC) without deterioration of quality of life (QOL) compared with surgical resection. The aim of...
Helicobacter pylori Eradication Downregulates Cellular Inhibitor of Apoptosis Protein 2 in Gastric Carcinogenesis

Yoon H, Kim SG, Kim BK, Shin E, Kim N, Lee HJ, Kang GH, Jung HC

  • Gut Liver.
  • 2017 Jan;11(1):79-86.
  • doi: 10.5009/gnl15585
BACKGROUND/AIMS: To evaluate the expression of cellular inhibitor of apoptosis protein 2 (cIAP2) during gastric carcinogenesis after Helicobacter pylori (HP) infection and after HP eradication. METHODS: We divided non-cancer patients into...
Underestimation of Smoking Rates in an East Asian Population with Crohn's Disease

Hwang SW, Seo H, Kim GU, Song EM, Seo M, Park SH, Kwon E, Lee HS, Yang DH, Kim KJ, Ye BD, Byeon JS, Myung SJ, Kim JH, Yang SK

  • Gut Liver.
  • 2017 Jan;11(1):73-78.
  • doi: 10.5009/gnl16194
BACKGROUND/AIMS: The reported rates of current smoking at the time of Crohn’s disease (CD) diagnosis tend to be low in East Asian studies. However, we hypothesized that East Asian patients...
Effectiveness of Capsule Endoscopy Compared with Other Diagnostic Modalities in Patients with Small Bowel Crohn’s Disease: A Meta-Analysis

Choi M, Lim S, Choi MG, Shim KN, Lee SH

  • Gut Liver.
  • 2017 Jan;11(1):62-72.
  • doi: 10.5009/gnl16015
BACKGROUND/AIMS: As a result of the rapid development of medical diagnostic tools, physicians require concrete evidence to evaluate the effectiveness of the tools. We aimed to investigate the effectiveness and...
Clinical Use of Measuring Trough Levels and Antibodies against Infliximab in Patients with Pediatric Inflammatory Bowel Disease

Choi SY, Kang B, Lee JH, Choe YH

  • Gut Liver.
  • 2017 Jan;11(1):55-61.
  • doi: 10.5009/gnl16041
BACKGROUND/AIMS: The clinical use of measuring infliximab (IFX) trough levels (TLs) and antibodies against IFX (ATIs) in patients with pediatric inflammatory bowel disease (IBD) remains unclear. We propose measuring these...
Factors That Affect Stent-Related Complications in Patients with Malignant Obstruction of the Esophagus or Gastric Cardia

Iwasaki H, Mizushima , Suzuki Y, Fukusada S, Kachi K, Ozeki T, Anbe K, Tsukamoto , Okumura F, Joh T, Sano H

  • Gut Liver.
  • 2017 Jan;11(1):47-54.
  • doi: 10.5009/gnl16172
BACKGROUND/AIMS: Self-expandable metallic stent (SEMS) placement is effective for dysphagia that results from malignant obstruction of the esophagus or gastric cardia; however, stent-related complications may be life-threatening. Thus, the goal...
CpG Island Methylator Phenotype-High Colorectal Cancers and Their Prognostic Implications and Relationships with the Serrated Neoplasia Pathway

Rhee YY, Kim KJ, Kang GH

  • Gut Liver.
  • 2017 Jan;11(1):38-46.
  • doi: 10.5009/gnl15535
The concept of a CpG island methylator phenotype (CIMP) was first introduced by Toyota and Issa to describe a subset of colorectal cancers (CRCs) with concurrent hypermethylation of multiple CpG...
25 Years of Proton Pump Inhibitors: A Comprehensive Review

Strand DS, Kim D, Peura DA

  • Gut Liver.
  • 2017 Jan;11(1):27-37.
  • doi: 10.5009/gnl15502
Proton pump inhibitors (PPIs) were clinically introduced more than 25 years ago and have since proven to be invaluable, safe, and effective agents for the management of a variety of...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: